OCGN compared with TENX: revenue, margins and what each company keeps, and the suppliers and customers both name

OCGNOcugen, Inc.

Mkt capRevenueRevenue

TENXTenax Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

OCGNOcugen, Inc.

TENXTenax Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

OCGN: latest quarter is a loss; flow not drawable. TENX: latest quarter not drawable.Method ›

Price

rebased to 0%

OCGN, solidTENX, dashed

OCGNOcugen, Inc.

0.71▼−4.80%· post 0.72

Mkt cap$238.3MRevenue$1MQ2 FY26Revenue$4MFY24

TENXTenax Therapeutics, Inc.

1.80▼−3.24%· post 1.79

ClosedOct 30 '26

Mkt cap$67.0MRevenue—Revenue—

Compare

ClosedOct 30 '26

OCGNOcugen, Inc.

TENXTenax Therapeutics, Inc.

0.71▼−4.80%post 0.72

Price

1.80▼−3.24%post 1.79

$238.3M

Mkt cap

$67.0M

Q2 FY26$1M

Revenue

—

FY24$4M

Revenue

—

OCGN0.71▼−4.80%vsTENX1.80▼−3.24%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only OCGN 11

—CanSino Biologicsunlistedsupplier

—CanSinoBIOunlistedsupplier

—National Institute of Allergy and Infectious Diseases (NIAID)unlistedsupplier

—Washington University in St. Louisunlistedsupplier

7 more · OCGN chain ›

Shared 0

No shared counterparties.

Only TENX 1

—Orionunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR